Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)

Treace Medical Concepts (TMCI) has 6 years of Asset Writedowns and Impairment data on file, last reported at -$69000.0 in Q3 2025.

• Quarterly Asset Writedowns and Impairment fell 139.66% year-over-year to -$69000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.1 million (down 60.6% YoY) and the FY2024 annual result came in at $2.9 million, up 579.03% from the prior year.
• Asset Writedowns and Impairment retreated to -$69000.0 in Q3 2025, from $81000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $2.0 million in Q2 2024 to a low of -$227000.0 in Q2 2022.
• A 5-year average of $260764.7 and a median of $156000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment plunged 150.94% — and 2024, when it soared 17300.0%.
• Tracing TMCI's Asset Writedowns and Impairment over 5 years: stood at $156000.0 in 2021, then soared by 187.82% to $449000.0 in 2022, then fell by 20.94% to $355000.0 in 2023, then jumped by 59.44% to $566000.0 in 2024, then plunged by 112.19% to -$69000.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at -$69000.0 (Q3 2025), $81000.0 (Q2 2025), and $500000.0 (Q1 2025), per Business Quant data.